Li-Wei Liu Selected Research

Li-Wei Liu Research Topics

Disease

10	Bacterial Infections (Bacterial Infection) 05/2022 - 08/2015
6	Neoplasms (Cancer) 02/2021 - 10/2010
5	Infections 12/2021 - 02/2016
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2017
3	Inflammation (Inflammations) 11/2019 - 01/2017
2	Body Weight (Weight, Body) 09/2022 - 03/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2021 - 01/2016
2	Hypoxia (Hypoxemia) 02/2021 - 01/2017
2	Oral Lichen Planus 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Asthma (Bronchial Asthma) 11/2019 - 01/2019
1	Thromboangiitis Obliterans (Buerger's Disease) 09/2022
1	Starvation 11/2021
1	COVID-19 10/2021
1	Thrombosis (Thrombus) 09/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2021
1	Adenocarcinoma 09/2020
1	Primary Myelofibrosis (Myelosclerosis) 09/2020
1	Sarcoma (Soft Tissue Sarcoma) 09/2020
1	Autoimmune Pancreatitis 06/2020
1	Immunoglobulin G4-Related Disease 06/2020
1	Pancreatic Diseases (Pancreatic Disease) 06/2020
1	Heart Failure 03/2020
1	Death (Near-Death Experience) 03/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2019
1	Airway Remodeling 11/2019
1	Infarction (Infarctions) 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 05/2018
1	Carcinoma (Carcinomatosis) 05/2018
1	Disease Resistance 04/2018
1	Osteomalacia 01/2018
1	Chronic Hepatitis B 01/2018
1	Hypophosphatemia 01/2018
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2018

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 04/2019
4	Agrochemicals (Agricultural Chemicals)IBA 08/2021 - 10/2019
4	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2013
3	Pharmaceutical PreparationsIBA 10/2021 - 07/2019
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Sulfides (Thioethers)IBA 12/2021 - 04/2019
2	HydrazinesIBA 08/2021 - 08/2020
2	1,3,4-oxadiazoleIBA 08/2021 - 04/2019
2	Therapeutic UsesIBA 01/2019 - 02/2016
2	Cadherins (E-Cadherin)IBA 05/2018 - 06/2015
1	Troleandomycin (TAO)FDA Link 09/2022
1	Hematoxylin (Haematoxylon)IBA 09/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2022
1	CoumarinsIBA 05/2022
1	monoisopropanolamineIBA 05/2022
1	Virulence Factors (Pathogenicity Factors)IBA 12/2021
1	Antiviral Agents (Antivirals)IBA 12/2021
1	1,2,4-triazoleIBA 12/2021
1	Biological ProductsIBA 12/2021
1	ChromatinIBA 11/2021
1	pyrazoleIBA 08/2021
1	PesticidesIBA 04/2021
1	CopperIBA 04/2021
1	Oxygen (Dioxygen)IBA 02/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021
1	fuzheng yiliuIBA 01/2021
1	fedratinibIBA 09/2020
1	Janus Kinase 2IBA 09/2020
1	PiperazineIBA 09/2020
1	AmidesIBA 09/2020
1	plasma protein Z (protein Z)IBA 08/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	Neprilysin (Neutral Endopeptidase)IBA 03/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2020
1	Drug CombinationsIBA 01/2020
1	XuebijingIBA 01/2020
1	asiatic acidIBA 01/2020
1	biapenem (L 627)IBA 01/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2019
1	CholesterolIBA 11/2019
1	Complement System Proteins (Complement)IBA 11/2019
1	furanIBA 10/2019
1	QuinazolinesIBA 10/2019
1	MicroRNAs (MicroRNA)IBA 08/2019
1	imidazoleIBA 04/2019
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 05/2018
1	Metalloproteases (Metalloproteinases)IBA 05/2018
1	Leucine-Rich Repeat ProteinsIBA 04/2018
1	Leucine (L-Leucine)FDA Link 04/2018
1	NucleotidesIBA 04/2018
1	adefovir dipivoxil (Hepsera)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 12/2017
1	Sincalide FDA Link 12/2017
1	DiglyceridesIBA 01/2017

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022 - 11/2019
1	Drug-Eluting Stents 09/2021
1	Stents 09/2021
1	Lasers (Laser) 02/2021
1	Photochemotherapy (Photodynamic Therapy) 02/2021
1	Pancreaticoduodenectomy 01/2020